Texas couple sentenced in smuggled vet drugs, pesticides case

A Texas couple has been sentenced in a federal case centered on the online sale of smuggled pesticides and unapproved veterinary drugs, underscoring how cross-border e-commerce can bypass core animal health safeguards. On September 8, 2026, Thao Duong of Garland, Texas, received three months in prison, two years of supervised release, and forfeiture of more than $1.5 million, while her husband, Lam Mai, was sentenced to two years of probation. Federal authorities said the pair operated a website that sold products smuggled from Mexico to customers nationwide. (ebs.publicnow.com)

The sentencing follows guilty pleas announced earlier this year. According to the Department of Justice, Duong pleaded guilty in January 2026 to conspiring to smuggle and sell unregistered pesticides and misbranded veterinary drugs. Mai, who worked as the shipping manager for the business, pleaded guilty to conspiracy charges involving the Federal Food, Drug, and Cosmetic Act and the Federal Insecticide, Fungicide, and Rodenticide Act. Prosecutors said Duong obtained roughly $2.4 million worth of smuggled merchandise between 2018 and 2022. (justice.gov)

The products at issue were not approved by the FDA for U.S. sale as veterinary drugs and were not registered with the EPA as pesticides, according to federal authorities. The case drew particular attention to amitraz-containing products, including Taktic and Bovitraz. EPA and DOJ materials have warned that these formulations are not registered for sale in the U.S., and that misuse in beehives can create risks for bees as well as potential human exposure through contaminated honey. EPA has separately issued guidance reminding the market that products used for varroa mite control in beehives must comply with federal pesticide law, even when beekeepers purchase them through informal or online channels. (epa.gov)

Federal agencies framed the case as part of a broader enforcement push. DOJ said smuggling prohibited and misbranded products into the U.S. and selling them to unsuspecting consumers endangers public health, while FDA’s animal health compliance materials emphasize that websites selling prescription veterinary medicines without a valid prescription are breaking the law. EPA has also repeatedly warned that online marketplaces can accelerate the spread of illegal pesticides, creating risks for consumers, pets, children, and others exposed during use or transport. (justice.gov)

There’s also a pattern here. Federal agencies have brought similar cases in California and elsewhere involving imported Mexican pesticides and veterinary drugs sold outside approved channels. That suggests this is not an isolated enforcement action, but part of a longer-running crackdown on gray-market and smuggled animal health products moving through border states and online storefronts. (justice.gov)

Why it matters: For veterinary professionals, the case is less about one website and more about supply-chain integrity. Products that bypass FDA approval or EPA registration may differ in formulation, labeling, concentration, language, storage history, or prescription status. That creates obvious risks for treatment failure, adverse events, toxic exposure, and client confusion. It also puts clinics in a difficult position when pet parents arrive with products bought online that look familiar, but aren’t legal U.S. versions. FDA’s consumer guidance now explicitly warns that suspiciously cheap veterinary medicines may be foreign-market or unapproved products, giving practices a clear opening for client education. (fda.gov)

For practices, the practical takeaway is to reinforce medication verification, document suspected adverse reactions or counterfeit concerns, and counsel pet parents on using reputable pharmacies and valid prescriptions. This case may also resonate beyond companion animal medicine, since amitraz-related enforcement has overlapped with apiculture and food-safety concerns tied to honey contamination. (epa.gov)

What to watch: Expect follow-on enforcement, possible additional warnings around online veterinary drug sales, and continued scrutiny of imported amitraz products and other animal health goods sold outside approved U.S. channels. (epa.gov)